Unknown

Dataset Information

0

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.


ABSTRACT: Chronic kidney disease (CKD) is a progressive loss of renal function. The gradual decline in kidney function leads to an accumulation of toxins normally cleared by the kidneys, resulting in uremia. Uremic toxins are classified into three categories: free water-soluble low-molecular-weight solutes, protein-bound solutes, and middle molecules. CKD patients have increased risk of developing cardiovascular disease (CVD), due to an assortment of CKD-specific risk factors. The accumulation of uremic toxins in the circulation and in tissues is associated with the progression of CKD and its co-morbidities, including CVD. Although numerous uremic toxins have been identified to date and many of them are believed to play a role in the progression of CKD and CVD, very few toxins have been extensively studied. The pathophysiological mechanisms of uremic toxins must be investigated further for a better understanding of their roles in disease progression and to develop therapeutic interventions against uremic toxicity. This review discusses the renal and cardiovascular toxicity of uremic toxins indoxyl sulfate, p-cresyl sulfate, hippuric acid, TMAO, ADMA, TNF-?, and IL-6. A focus is also placed on potential therapeutic targets against uremic toxicity.

SUBMITTER: Lim YJ 

PROVIDER: S-EPMC7917723 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.

Lim Yong Jin YJ   Sidor Nicole A NA   Tonial Nicholas C NC   Che Adrian A   Urquhart Bradley L BL  

Toxins 20210213 2


Chronic kidney disease (CKD) is a progressive loss of renal function. The gradual decline in kidney function leads to an accumulation of toxins normally cleared by the kidneys, resulting in uremia. Uremic toxins are classified into three categories: free water-soluble low-molecular-weight solutes, protein-bound solutes, and middle molecules. CKD patients have increased risk of developing cardiovascular disease (CVD), due to an assortment of CKD-specific risk factors. The accumulation of uremic t  ...[more]

Similar Datasets

| S-EPMC8494360 | biostudies-literature
| S-EPMC8745705 | biostudies-literature
| S-EPMC8792216 | biostudies-literature
| S-EPMC5592833 | biostudies-literature
| S-EPMC5199014 | biostudies-literature
| S-EPMC2275772 | biostudies-other
| S-EPMC5983260 | biostudies-literature
| S-EPMC8520534 | biostudies-literature
| S-EPMC10143607 | biostudies-literature
| S-EPMC7940523 | biostudies-literature